Melatonin reduces nitric oxide via increasing arginase in rhabdomyolysis-induced acute renal failure in rats

Renal Failure

Volumn 28, Issue 5, 2006, Pages 435-440

  Aydogdu, Nurettin ^a   Erbas, Hakan ^a   Atmaca, Gulizar ^a   Erten, Oya ^a   Kaymak, Kadir ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Arginase; Melatonin; Myoglobinuric acute renal failure; Nitric oxide; Ornithine

Indexed keywords

ARGINASE; GLYCEROL; MELATONIN; NITRIC OXIDE; ORNITHINE; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; KIDNEY; MALE; MYOGLOBINURIA; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT; RHABDOMYOLYSIS;

ANIMALS; ARGINASE; GLYCEROL; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; MELATONIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; RANDOM ALLOCATION; RATS; RHABDOMYOLYSIS;

EID: 33745887759     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220600683631     Document Type: Article

References (31)

1. Vanholder R, Sever MS, Erek E, et al. Rhabdomyolysis. J Am Soc Nephrol. 2000;11:1553-1561.
2. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996;49:314-326.
3. Baliga R, Zhang Z, Baliga M, et al. Evidence for cytochrome p-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int. 1996;49(2):362-369.
4. Reiter RJ, Tan DX, Burkhardt S. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Ageing Dev. 2002;123:1007-1019.
5. Tan DX, Manchester LC, Reiter RJ, et al. Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept. 2000;9:137-159.
6. Morris SM. Enzymes of arginine metabolism. J Nutr. 2004;134:2743S-2747S.
7. Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci. 1999; 55:1015-1028.
8. Cherla G, Jaimes EA. Role of L-arginine in the pathogenesis and treatment of renal disease. J Nutr. 2004;134:2801S-2806S.
9. Jeon J, Acuna-Castroviejo D, Sainz RM, et al. Melatonin nd mitochondrial function. Life Sci. 2004;75:765-790.
10. Ash DE. Structure and function of arginases. J Nutr. 2004;134:2760S- 2764S.
11. Lowe DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide. 2000;4:441-458.
12. Geyer JW, Dabich D. Rapid method for determination of arginase activity in tissue homogenates. Anal Biochem. 1971;39:412-417.
13. Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem. 1952;199:91-95.
14. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem. 1951; 193:265-275.
15. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem. 1990;36:1440-1443.
16. Que LG, Kantrow SP, Jenkinson CP, et al. Induction of arginase isoforms in the lung during hyperoxia. Am J Physiol. 1998;275:96-102.
17. Li H, Meininger CJ, Hawker JR, et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab. 2001;280:75-82.
18. Ishii N, Ikenaga H, Carmines PK, et al. High glucose augments arginase activity and nitric oxide production in the renal cortex. Metabolism. 2004;53(7):868-874.
19. Jansen A, Lewin S, Cattell V, et al. Arginase is a major pathway of L-arginine metabolism in nephritic glomeruli. Kidney Int. 1992;42:1107-1112.
20. Durak I, Ozturk HS, Elgun S, et al. Erythrocyte nitric oxide metabolism in patients with chronic renal failure. Clin Nephrol. 2001;55:460-464.
21. Erbas H, Aydogdu N, Kaymak K. Effects of N-acetylcysteine on arginase, ornithine and nitric oxide in renal ischemia-reperfusion injury. Pharmacol Res. 2004;50:523-527.
22. Cook HT, Jansen A, Lewis S, et al. Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase. Am J Physiol. Renal Physiol. 1994;267:F646-F653.
23. Zhang C, Hein TW, Wanng W, et al. Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB. 2001;15:1264-1266.
24. Turjanski AG, Leonik F, Estrin DA, et al. Scavenging of nitric oxide by melatonin. J Am Chem Soc. 2000;122:10468-10469.
25. Rao VSN, Santos FA, Silva RM, et al. Effect of nitric oxide synthase inhibitors and melatonin on the hyperglycemic response to streptozotocin in rats. Vascul Pharmacol. 2002;38:127-130.
26. Zhang S, Li W, Gao Q, et al. Effect of melatonin on the generation of nitric oxide in murine macrophages. Eur J Pharmacol. 2004;501:25-30.
27. Aarseth JJ, Nordoy ES, Stokkan KA. Melatonin potentiates the vasoconstrictive effect of noradrenaline in renal artery from newborn hooded seals (Cystophora cristata) and harp seals (Phoca groenlandica). J Comp Physiol [B]. 2001;171:491-496.
28. Sokkary GHE, Omar HM, Hassanein AFMM, et al. Melatonin reduces oxidative damage and increases survival of mice infected with Schistosoma mansoni. Free Rad Biol Med. 2002;32(4):319-332.
29. Aydogdu N, Atmaca G, Yalcin O, et al. Effects of exogenous melatonin on myoglobinuric acute renal failure in the rats. Ren Fail. 2004;26(5):479-486.
30. Maree A, Peer G, Schwartz DA, et al. Role of nitric oxide in glycerol-induced acute renal failure in rats. Nephrol Dial Transplant. 1994;9(Suppl.):78-81.
31. Ferraz, FF, Kos AG, Janino P, Homsi E. Effects of melatonin administration to rats with glycerol-induced acute renal failure. Ren Fail. 2002;24(6):735-746.